S.2478 - End Taxpayer Subsidies for Drug Ads Act115th Congress (2017-2018) |
|Sponsor:||Sen. McCaskill, Claire [D-MO] (Introduced 03/01/2018)|
|Committees:||Senate - Finance|
|Latest Action:||Senate - 03/01/2018 Read twice and referred to the Committee on Finance. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
Summary: S.2478 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in Senate (03/01/2018)
End Taxpayer Subsidies for Drug Ads Act
This bill amends the Internal Revenue Code to prohibit tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.
"Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is: (1) in regard to the drug product, and (2) primarily targeted to the general public.